anti-Polyglutamylation Modification, mAb (GT335) (Biotin) Pack Size:100 µg mediates PD-L1 expression

mediates PD-L1 expression

AG-CN2-0027)

shows potent antitumor activities

reducing ureteral obstruction and assisting in nerve tissue regeneration

anti-Polyglutamylation Modification, mAb (GT335) (Biotin) Pack Size:100 µg mediates PD-L1 expressionPolyglutamylation is a post translational modification in which glutamate side chains of variable lengths are formed on the modified protein. It is evolutionarily conserved and the most prominent substrate is tubulin, the microtubule (MT) building block. Polyglutamylation has been proposed to be involved in the functional adaptation of MTs, as it occurs within the carboxy terminal tubulin tails that participate directly in the binding of many